The introduction of the EML4-ALK mutation in the cell line was confirmed via Sanger sequencing as shown in Figure 2 (A, B) for the expected 5p and 3p genomic breakpoints. Sanger sequencing of ...

The research team split 296 patients with the ALK mutation into groups and gave half ... for its “off the charts” results after a trial found it improved survival rates by the longest period ...

Scientists said the results were 'off the charts' following a trial which ... advanced non-small cell lung cancer caused by a mutation of the ALK gene, an aggressive form of the disease which ...